Pregnancy: For esomeprazole limited data on exposed pregnancies are available. Animal studies with esomeprazole do not indicate direct or indirect harmful effects with respect to embryonal/foetal development. Animal studies with the racemic mixture do not indicate direct or indirect harmful effects with respect to pregnancy, parturition or postnatal development. Caution should be exercised when prescribing Vaxcel Esomeprazole 40mg Powder for Injection to pregnant women.
Breast-Feeding: It is not known whether esomeprazole is excreted in human breast milk. No studies in lactating women have been performed. Therefore Vaxcel Esomeprazole 40mg Powder for Injection should not be used during breast feeding.